Literature DB >> 22127370

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis.

Anuja Dokras1, Shari Clifton, Walter Futterweit, Robert Wild.   

Abstract

OBJECTIVE: To perform a systematic review and meta-analysis of studies that compared the prevalence of anxiety symptoms in women with polycystic ovary syndrome (PCOS) and control women.
DESIGN: Meta-analysis and systematic review.
SETTING: University practice. PATIENT(S): Cross-sectional studies comparing PCOS subjects and geographically matched clearly defined non-PCOS control subjects with data on age and body mass index (BMI). INTERVENTION(S): Anxiety screening tool. MAIN OUTCOME MEASURE(S): The primary analysis contrasted prevalence of anxiety. Cochrane Review Manager 5.0.24 software was used to construct forest plots comparing frequency of anxiety symptoms in case and control subjects. RESULT(S): Of 613 screened articles, nine met our selection criteria for a systematic review and four were included in the meta-analysis. The prevalence of generalized anxiety symptoms was available in four studies and was significantly greater in PCOS subjects (42/206, 20.4%) compared to controls (8/204, 3.9%). The odds for anxiety symptoms were significantly greater in women with PCOS compared with control subjects (odds ratio 6.88, 95% confidence interval 2.5-18.9). The mean anxiety score was significantly increased in three of the remaining five studies. Other anxiety disorders, such as social phobia, panic attacks, and obsessive compulsive disorders, were assessed infrequently. CONCLUSION(S): Our systematic review suggests an increased odds of anxiety symptoms in women with PCOS, underscoring the importance of screening all women with PCOS for anxiety symptoms. Follow-up evaluation and treatment are essential, because generalized anxiety disorder is a chronic condition. Potential contributors for anxiety symptoms, such as hirsutism, obesity, and/or infertility may be specific to women with PCOS but need further investigation.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22127370     DOI: 10.1016/j.fertnstert.2011.10.022

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  40 in total

1.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

Review 2.  Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies.

Authors:  Manmohan K Kamboj; Andrea E Bonny
Journal:  Transl Pediatr       Date:  2017-10

3.  Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome.

Authors:  Ilana B Ressler; Bernadette E Grayson; Randy J Seeley
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

4.  A Theoretically Grounded Exploration of Individual and Family Self-Management of Polycystic Ovary Syndrome in Adolescents.

Authors:  Cara C Young; Atami O Sagna; Maria Monge; Lynn Rew
Journal:  Compr Child Adolesc Nurs       Date:  2019-10-23

5.  Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.

Authors:  Melanie Gibson-Helm; Helena Teede; Andrea Dunaif; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

6.  Transition to Self-Management among Adolescents with Polycystic Ovary Syndrome: Parent and Adolescent Perspectives.

Authors:  Cara C Young; Lynn Rew; Maria Monge
Journal:  J Pediatr Nurs       Date:  2019-05-09       Impact factor: 2.145

7.  Maternal polycystic ovarian syndrome and early offspring development.

Authors:  Griffith A Bell; Rajeshwari Sundaram; Sunni L Mumford; Hyojun Park; James Mills; Erin M Bell; Miranda Broadney; Edwina H Yeung
Journal:  Hum Reprod       Date:  2018-07-01       Impact factor: 6.918

8.  Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety.

Authors:  Snigdha Alur-Gupta; Anat Chemerinski; Chang Liu; Jenna Lipson; Kelly Allison; Mary D Sammel; Anuja Dokras
Journal:  Fertil Steril       Date:  2019-08-05       Impact factor: 7.329

9.  Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis.

Authors:  Eleni A Greenwood; Kristine Yaffe; Melissa F Wellons; Marcelle I Cedars; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

10.  Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.

Authors:  Min Hu; Jennifer Elise Richard; Manuel Maliqueo; Milana Kokosar; Romina Fornes; Anna Benrick; Thomas Jansson; Claes Ohlsson; Xiaoke Wu; Karolina Patrycja Skibicka; Elisabet Stener-Victorin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.